Qube Research & Technologies (QRT)
RVLP

Qube Research & Technologies (QRT)’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50
Closed -$4 – 4918
2023
Q3 		$4 Buy
+50
New +$14 ﹤0.01% 3982

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RVLP Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 50 shares — an estimated $4 sold.

Qube Research & Technologies (QRT) first reported a position in RVLP in Q3 2023 and held it in 1 quarter. The position peaked at $4 in Q3 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 50 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $4.
  • Qube Research & Technologies (QRT) first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2023 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s RVL Pharmaceuticals plc Ordinary Shares position peaked at $4 in Q3 2023.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.